|View printer-friendly version|
|July 11, 2018 8:00 a.m.|
|Teva to Report Second Quarter 2018 Financial Results on August 2, 2018|
Teva will host a conference call and live webcast on the same day, at
In order to participate, please dial the following numbers (at least 10 minutes before the scheduled start time):
A live webcast of the call will also be available on Teva's website at: ir.tevapharm.com Please log in at least 10 minutes prior to the conference call in order to download the applicable software.
Following the conclusion of the call, a replay of the webcast will be
available within 24 hours on the Company's website. The replay can also
be accessed until
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 regarding Teva's generic version of Uceris®, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include risks relating to:
and other factors discussed in our Annual Report on Form 10-K for the
Teva Pharmaceutical Industries Ltd.